Iatreia (Jul 2014)
Human immunodeficiency virus type 1 (HIV-1) reservoirs: mechanisms of latency and therapeutic strategies = Reservorios del virus de inmunodeficiencia humana tipo 1 (VIH-1): mecanismos de latencia y estrategias terapéuticas
Abstract
The human immunodeficiency virus type 1 can establish a latent infection in different kind of cells, which constitute the cellular reservoirs for the virus and allow its maintenance in the body indefinitely, even in patients with antiretroviral treatment. The main reservoirs of the HIV-1 are resting CD4+ T cells, although cells like monocytes/macrophages, dendritic cells, and other cells like hematopoietic stem cells and mast cells may be reservoirs of the virus. There are different mechanisms that contribute to the establishment and maintenance of latency in those cells, and include transcriptional interference, low availability of transcription factors, chromatin condensation, some microRNA that block viral translation, and so on. The knowledge of these mechanisms is crucial for the development of new drugs that may eliminate the virus from the body and lead to a cure.
